Daniel Muñoz

26.5k total citations · 6 hit papers
81 papers, 12.1k citations indexed

About

Daniel Muñoz is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and General Health Professions. According to data from OpenAlex, Daniel Muñoz has authored 81 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cardiology and Cardiovascular Medicine, 24 papers in Surgery and 7 papers in General Health Professions. Recurrent topics in Daniel Muñoz's work include Cardiac Arrhythmias and Treatments (16 papers), Cardiac pacing and defibrillation studies (13 papers) and Cardiac Valve Diseases and Treatments (11 papers). Daniel Muñoz is often cited by papers focused on Cardiac Arrhythmias and Treatments (16 papers), Cardiac pacing and defibrillation studies (13 papers) and Cardiac Valve Diseases and Treatments (11 papers). Daniel Muñoz collaborates with scholars based in Spain, United States and Mexico. Daniel Muñoz's co-authors include Erin D. Michos, Donald M. Lloyd‐Jones, John W. McEvoy, Michael D. Miedema, Salim S. Virani, Cheryl Dennison Himmelfarb, Boback Ziaeian, Ellen J. Hahn, Zachary D. Goldberger and Roger S. Blumenthal and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Daniel Muñoz

69 papers receiving 11.8k citations

Hit Papers

2019 ACC/AHA Guideline on the Primary Prevention of Cardi... 2016 2026 2019 2022 2019 2019 2016 2019 2019 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
    2019 3.6k citations Donna K. Arnett, Roger S. Blumenthal et al. Circulation profile →
  2. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
    2019 3.0k citations Donna K. Arnett, Roger S. Blumenthal et al. Circulation profile →
  3. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
    2016 1.8k citations José Luis Zamorano, Patrizio Lancellotti et al. European Heart Journal profile →
  4. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
    2019 1.2k citations Donna K. Arnett, Roger S. Blumenthal et al. Journal of the American College of Cardiology profile →
  5. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
    2019 804 citations Donna K. Arnett, Roger S. Blumenthal et al. Journal of the American College of Cardiology profile →
  6. 2017 ESC/EACTS Guidelines for the Management of Valvular Heart Disease
    2018 362 citations Patrizio Lancellotti, Daniel Muñoz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Muñoz Spain 23 6.6k 2.7k 1.8k 1.7k 1.6k 81 12.1k
Michael J. Pencina United States 35 6.6k 1.0× 2.3k 0.9× 2.6k 1.5× 1.3k 0.8× 1.1k 0.7× 46 14.7k
Boback Ziaeian United States 29 6.2k 0.9× 2.7k 1.0× 2.0k 1.1× 1.2k 0.7× 1.7k 1.0× 111 12.4k
Joseph Yeboah United States 33 7.0k 1.1× 3.3k 1.2× 2.4k 1.3× 2.3k 1.3× 1.7k 1.0× 133 13.5k
Michelle A. Albert United States 42 6.1k 0.9× 3.6k 1.3× 2.4k 1.3× 1.2k 0.7× 2.4k 1.5× 115 15.6k
Jarett D. Berry United States 56 7.1k 1.1× 2.2k 0.8× 2.1k 1.2× 1.3k 0.7× 1.2k 0.8× 196 12.6k
Michael D. Miedema United States 33 5.9k 0.9× 3.6k 1.4× 2.1k 1.2× 2.6k 1.5× 1.7k 1.0× 120 12.2k
Jean Ferrières France 64 6.5k 1.0× 4.0k 1.5× 2.9k 1.6× 1.0k 0.6× 1.8k 1.1× 524 15.5k
Colby Ayers United States 56 6.7k 1.0× 2.6k 1.0× 2.1k 1.2× 1.7k 1.0× 1.0k 0.7× 269 12.5k
Keaven M. Anderson United States 55 7.5k 1.1× 4.3k 1.6× 2.8k 1.6× 1.7k 1.0× 1.4k 0.9× 116 14.4k
John W. McEvoy United States 44 7.8k 1.2× 4.3k 1.6× 3.1k 1.7× 2.3k 1.4× 2.0k 1.2× 261 16.4k

Countries citing papers authored by Daniel Muñoz

Since Specialization
Citations

This map shows the geographic impact of Daniel Muñoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Muñoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Muñoz more than expected).

Fields of papers citing papers by Daniel Muñoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Muñoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Muñoz. The network helps show where Daniel Muñoz may publish in the future.

Co-authorship network of co-authors of Daniel Muñoz

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Muñoz. A scholar is included among the top collaborators of Daniel Muñoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Muñoz. Daniel Muñoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Benziger, Catherine P., Amanda Stebbins, Lisa Wruck, et al.. (2024). Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients. JAMA Cardiology. 9(9). 808–808. 3 indexed citations
3.
4.
Jiménez, Javier Ramos, et al.. (2024). Double-balloon distal protection for vein of Marshall ethanol infusion in presence of persistent left superior vena cava. Journal of Interventional Cardiac Electrophysiology. 68(7). 1379–1380.
5.
Clark, Daniel E., et al.. (2023). Massive Left Ventricular Aneurysm After Inferior Infarction. SHILAP Revista de lepidopterología. 2(5). 1 indexed citations
6.
Mulder, Hillary, Lisa Wruck, E. Hope Weissler, et al.. (2023). Internet Versus Noninternet Participation in a Decentralized Clinical Trial: Lessons From the ADAPTABLE Study. Journal of the American Heart Association. 12(13). e027899–e027899. 4 indexed citations
7.
8.
Jiménez, Javier Ramos, et al.. (2021). Complete interatrial block in a left‐atrial dependent atrioventricular node. Journal of Cardiovascular Electrophysiology. 32(8). 2343–2345.
9.
Arnett, Donna K., Roger S. Blumenthal, Michelle A. Albert, et al.. (2019). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 140(11). e596–e646. 3038 indexed citations breakdown →
10.
Arnett, Donna K., Roger S. Blumenthal, Michelle A. Albert, et al.. (2019). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary. Journal of the American College of Cardiology. 74(10). 1376–1414. 804 indexed citations breakdown →
11.
Muñoz, Daniel, Heather M. Munro, Wen‐Liang Song, et al.. (2019). Polypill for Cardiovascular Disease Prevention in an Underserved Population. New England Journal of Medicine. 381(12). 1114–1123. 120 indexed citations
12.
13.
Zamorano, José Luis, Patrizio Lancellotti, Daniel Muñoz, et al.. (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. European Heart Journal. 37(36). 2768–2801. 1750 indexed citations breakdown →
14.
Fernández‐Golfín, Covadonga, Ariana González-Gómez, Ana García‐Martin, et al.. (2016). Area strain from 3D speckle-tracking echocardiography as an independent predictor of early symptoms or ventricular dysfunction in asymptomatic severe mitral regurgitation with preserved ejection fraction. International journal of cardiac imaging. 32(8). 1189–1198. 14 indexed citations
15.
Zamorano, José Luis, Patrizio Lancellotti, Daniel Muñoz, et al.. (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Kardiologia Polska. 74(11). 1193–1233. 55 indexed citations
16.
Bachmann, Justin M., Kenneth A. Wallston, Christianne L. Roumie, et al.. (2015). Abstract 11771: Health Self-efficacy is Associated With Increased Physical Activity in Patients With Coronary Heart Disease. Circulation. 132(suppl_3). 1 indexed citations
17.
Muñoz, Daniel, et al.. (2015). Use of left ventricular flow mapping in echocardiographic optimization of atrioventricular delay:. European Heart Journal - Cardiovascular Imaging. 16(10). 1170–1170. 2 indexed citations
18.
Cetina, Lucely, Aarón González-Enciso, David Cantú de León, et al.. (2013). Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2–IIB cervical cancer patients. Annals of Oncology. 24(8). 2043–2047. 60 indexed citations
19.
Bagai, Akshay, Hussein R. Al‐Khalidi, Daniel Muñoz, et al.. (2013). Bypassing the Emergency Department and Time to Reperfusion in Patients With Prehospital ST-Segment–Elevation. Circulation Cardiovascular Interventions. 6(4). 399–406. 31 indexed citations
20.
Fitó, Montserrat, M Cladellas, Rafael de la Torre, et al.. (2007). Anti-inflammatory effect of virgin olive oil in stable coronary disease patients: a randomized, crossover, controlled trial. European Journal of Clinical Nutrition. 62(4). 570–574. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael J. Pencina Breakdown of academic impact, for papers by Boback Ziaeian Breakdown of academic impact, for papers by Joseph Yeboah Breakdown of academic impact, for papers by Michelle A. Albert Breakdown of academic impact, for papers by Jarett D. Berry Breakdown of academic impact, for papers by Michael D. Miedema Breakdown of academic impact, for papers by Jean Ferrières Breakdown of academic impact, for papers by Colby Ayers Breakdown of academic impact, for papers by Keaven M. Anderson Breakdown of academic impact, for papers by John W. McEvoy
Rankless by CCL
2026